E

Edgewise Therapeutics

EWTX

16.730
USD
-0.3
(-1.76%)
Market Closed
Volume
10,431
EPS
0
Div Yield
0
P/E
-22
Market Cap
3,187,320,069
News

Title: Edgewise Therapeutics

Sector: Healthcare
Industry: Biotechnology
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases.